Physician

Mark D Carlson, MD

According to 2025 Medicare claims, Mark Carlson, MD (NPI: 1023008398) practices hematology/oncology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is BE WELL MD PLLC (NPI: 1780128140; TIN: 465219431) and primary practice location at 68516-5536.

Carlson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 46 traditional Medicare patients, billed 14,307 HCPCS/CPT codes, and received $30,809 in Medicare payments. The top billing code was 99350 (Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes). Part D data shows 1,174 prescription claims across 49 beneficiaries totaling $68,246 in drug costs, led by Jardiance (Empagliflozin). 2022 DME data shows 41 claims. Open Payments data shows 116 records totaling $1,551,875. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $27,246 and ending at $30,809. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,719 and ending at $68,246. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,179 and ending at $5,463.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	100	338	$27,246
2018	101	419	$25,543
2019	274	32,661	$383,612
2020	120	292	$18,288
2021	69	427	$30,743
2022	54	349	$23,107
2023	42	232	$13,944
2024	46	14,307	$30,809

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	119	$9,719
2016	28	307	$28,633
2017	70	722	$49,582
2018	164	1,081	$96,036
2019	163	1,383	$234,987
2020	157	2,162	$169,414
2021	142	2,880	$248,966
2022	101	2,170	$199,250
2023	63	1,667	$148,122
2024	49	1,174	$68,246

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	48	$2,338
2020	N/R	14	$193
2021	N/R	137	$14,924
2022	N/R	41	$1,287
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99350	Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes	22	26	$91
99349	Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes	27	61	$71
99348	Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes	30	58	$49

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	13	630	$11,218
Eliquis	Apixaban	13	354	$7,462
Propranolol Hcl Er	Propranolol Hcl	28	992	$1,535
Donepezil Hcl	Donepezil Hcl	53	1,627	$1,006
Potassium Chloride	Potassium Chloride	46	1,570	$910

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$97	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	114	$1,551,778	ModernaTX, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark D. Carlson, MD?

Tedicare shows public-source Medicare data for Mark D. Carlson, MD (NPI 1023008398), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark D. Carlson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark D. Carlson, MD?

Mark D. Carlson, MD is linked to BE WELL MD PLLC (billing NPI 1780128140) in the available physician profile data.

Does Mark D. Carlson, MD have Open Payments data?

Mark D. Carlson, MD has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.